FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
Executive Summary
Sponsors and FDA reviewers will have to adjust to the workload of a drug review shifting earlier in the review cycle as the agency implements Good Review Management Principles, now renamed the "21 Century Review Process.
You may also be interested in...
The Good Old Days: FDA's Jenkins Instructs Reviewers To Meet Original User Fee Review Time Standard
Office of New Drugs Director instructs FDA reviewers to return to the practice of meeting 90 percent of their review time goals for new drug applications.
Comparative Effectiveness Reaches Into Drug Reviews, FDA Documents Show
As the health care reform debate focuses on the appropriate role of comparative effectiveness research, a look at FDA’s review practices gives some insight into how the agency already takes the concept into account in its review decisions.
Comparative Effectiveness Reaches Into Drug Reviews, FDA Documents Show
As the health care reform debate focuses on the appropriate role of comparative effectiveness research, a look at FDA’s review practices gives some insight into how the agency already takes the concept into account in its review decisions.